Back to 2017 Annual Meeting Program
Anatomical/Technical Predictors of Perioperative Clinical Outcomes after Carotid Artery Stenting
Ali F AbuRahma, John E Campbell, Aravinda Nanjundappa, Trevor DerDerian, Nizar Hariri, Elliott Adams, L Scott Dean, Joseph AbuRahma
Robert C. Byrd Health Sciences Center of W. Va. Univ., Charleston, WV
Background: Only a few studies have reported on the impact of anatomical/technical factors on clinical outcomes of carotid artery stenting (CAS). This study will analyze the effect of these factors on perioperative stroke/death after CAS.
Population and Methods: This is a retrospective analysis of prospectively collected data on 456 CAS patients. A logistic regression analysis was used to determine the impact of anatomical factors (lesion length, location, severity, calcification, and arch type) and technical factors (stent type, number, diameter, and length; filter type, filter insertion to recovery time, and pre- and post-stent PTA) on perioperative stroke, death, and myocardial infarction (MI;major adverse events [MAE]).
Results: The MAE and stroke rates for the whole series were 4.7% and 2.2%. The stroke rate for asymptomatic patients was 0.46% (p=0.01). The MAE rates for patients with transient ischemic attacks (TIA) were 7% versus 3.2% for other indications (p=0.077). The stroke rates for calcific lesions were 6.3% versus 1.2% for non-calcific lesions (p=0.046). There were no significant differences in stroke and MAE rates in regards to other anatomical features.
The stroke rate for patients with dilatation prior to filter insertion with pre-stent and/or post-stent PTA was 9.1% versus 1.8% for patients without (p=0.07;) and 2.6% for patients with post-stenting dilatation versus 0% for patients without (p=0.36). MAE rates for patients with post-stenting dilatation were 5.6% versus 0% for patients without (p=0.0536). MAE rates for patients with ACCUNET filters were 1.9% versus 6.7% for other filters (p=0.029). There were no significant differences between stroke and MAE rates in regards to stent type, number, diameter, length of stent, and time from filter insertion to recovery time.
A regression analysis showed that the odds ratio for stroke was 0.1 (p=0.031) for asymptomatic indications, 13.7 (p=0.014) for TIA indications, 6.1 (p=0.0303) for dilatation performed prior to filter insertion, and 1.7 (p=0.4413) for PTA performed prior to stenting. It also showed that the MAE odds ratio was 0.46 (p=0.0858) for asymptomatic indications, 2.1 (p=0.35) for pre-dilatations performed prior to filter insertion, and 2.2 (p=0.22) for post-stent dilatations. A multivariate analysis showed that patients with TIA indications had an odds ratio of stroke of 15.26 (p=0.0113); and patients with dilations performed prior to filter insertion with pre-stent and/or post-stent PTA had an odds ratio of 7.98 (p=0.0193). The MAE odds ratio for ACCUNET versus other filters was 0.27 (p=0.0389, Tables).
Conclusions: PTA prior to filter insertion had higher stroke rates and post-stenting PTA was associated with higher MAE rates. The ACCUNET filter was associated with lower stroke and MAE rates. There was no correlation between other anatomical/technical variables.
Table
PTA Combination and Perioperative Stroke and Major Adverse Events
Dilation | Stroke No. (%) | MAE No. (%) |
None | 0/26 | 0/26 |
Pre-EPD only | 0/1 | 0/1 |
Pre-stent only | 0/39 | 0/39 |
Post-stent only | 2/130 (1.5) | 6/130 (4.6) |
Pre-EPD & pre-stent | 0/2 | 0/2 |
Pre-EPD & post-stent | 1/8 (12.5) | 1/8 (12.5) |
Pre-stent & post-stent | 5/192 (2.6) | 11/192 (5.7) |
Pre-EPD, pre-stent & post- stent | 1/11 (9.1) | 1/11 (9.1) |
Table
Logistic Regression Analysis
Univariate - Early Stroke | |||||||
Variable | OR | 95% CI | p-value | ||||
Age | 1.03 | (0.96,1.11) | 0.4058 | ||||
Gender (Male vs Female) | 0.86 | (0.23,3.24) | 0.8223 | ||||
Hypertension | 1.04 | (0.13,8.52) | 0.9683 | ||||
Coronary Artery Disease | 1.33 | (0.27,6.51) | 0.7215 | ||||
Congestive Heart Failure | 1.63 | (0.4,6.61) | 0.4977 | ||||
Hypercholesterolemia | 1.10 | (0.23,5.4) | 0.9026 | ||||
Renal Failure | 1.00 | (0.21,4.91) | 0.9971 | ||||
Asymptomatic Indication | 0.10 | (0.01,0.81) | 0.031 | ||||
TIA Indication | 13.69 | (1.7,110.47) | 0.014 | ||||
Stroke Indication | 1.10 | (0.14,9.02) | 0.9273 | ||||
Pre-ProcedureStenosis (70-99 vs 50-69) | 0.56 | (0.07,4.6) | 0.5852 | ||||
Lesion Length (> 15 mm) | 0.96 | (0.25,3.62) | 0.9501 | ||||
Pre-dilatation Performed Prior to EPD* | 6.09 | (1.19,31.2) | 0.0303 | ||||
Pre-dilatation Performed Prior to Stent | 1.73 | (0.43,7.01) | 0.4413 | ||||
Univariate - Early MI/Stroke/Death | |||||||
Variable | OR | 95% UCL | p-value | ||||
Age | 1.02 | (0.97,1.06) | 0.5127 | ||||
Gender (Male vs Female) | 1.00 | (0.42,2.38) | 0.9913 | ||||
Hypertension | 0.42 | (0.15,1.19) | 0.101 | ||||
Coronary Artery Disease | 1.01 | (0.39,2.65) | 0.981 | ||||
Congestive Heart Failure | 0.94 | (0.34,2.62) | 0.9102 | ||||
Hypercholesterolemia | 0.66 | (0.26,1.66) | 0.3781 | ||||
Renal Failure | 1.34 | (0.51,3.51) | 0.5558 | ||||
Asymptomatic Indication | 0.46 | (0.19,1.12) | 0.0858 | ||||
TIA Indication | 2.04 | (0.86,4.82) | 0.1055 | ||||
Stroke Indication | 0.88 | (0.2,3.87) | 0.8603 | ||||
Pre-procedureStenosis (70-99 vs 50-69) | 0.58 | (0.13,2.66) | 0.4833 | ||||
Lesion Length (> 15 mm) | 0.43 | (0.17,1.12) | 0.0831 | ||||
EPD* (ACCUNET vs Other) | 0.27 | (0.08,0.95) | 0.0413 | ||||
Pre-dilatation Performed Prior to EPD* | 2.07 | (0.45,9.45) | 0.35 | ||||
Pre-dilatation Performed Prior to Stent | 1.03 | (0.44,2.43) | 0.9463 | ||||
Post-Stent Dilatation Performed | 2.16 | (0.63,7.43) | 0.2232 | ||||
Multivariate | |||||||
Early Stroke | |||||||
Variable | OR | 95% CI | p-value | ||||
TIA Indication | 15.26 | (1.85,125.66) | 0.0113 | ||||
Pre-dilatation Performed Prior to EPD* | 7.98 | (1.4,45.43) | 0.0193 | ||||
Multivariate | |||||||
Early MI/Stroke/Death | |||||||
Variable | OR | 95% LCL | p-value | ||||
EPD* - ACCUNET vs Other | 0.27 | (0.08,0.94) | 0.0389 |
* EPD (Embolic Protection Device)
Back to 2017 Annual Meeting Program